Variable | Q1 (n = 273) | Q2 (n = 273) | Q3 (n = 273) | Q4 (n = 273) | P value |
---|---|---|---|---|---|
TyG index | 8.373 ± 0.258 | 8.905 ± 0.122 | 9.345 ± 0.145 | 10.076 ± 0.483 | < 0.001 |
Age, years | 65.2 ± 13.2 | 63.5 ± 10.8 | 61.2 ± 11.6 | 57.6 ± 12.4 | < 0.001 |
Male | 219 (80.2) | 220 (80.6) | 222 (81.3) | 213 (78.0) | 0.546 |
BMI, kg/m2 | 25.2 (24.7–25.5) | 25.5 (25.1–25.8) | 26.0 (25.6–26.2) | 26.5 (26.0–26.9) | 0.012 |
SBP, mmHg | 124.9 ± 22.1 | 128.7 ± 21.9 | 129.9 ± 20.8 | 138.3 ± 22.6 | < 0.001 |
DBP, mmHg | 75.2 ± 14.1 | 76.6 ± 13.4 | 77.1 ± 14.3 | 84.7 ± 16.8 | < 0.001 |
Heart rate, bpm | 77.7 ± 14.5 | 79.7 ± 13.1 | 79.0 ± 12.7 | 82.2 ± 16.3 | 0.019 |
Killip class > 1 | 82 (30.3) | 85 (31.1) | 91 (33.3) | 89 (32.6) | 0.523 |
Smoker | 114 (41.8) | 120 (44.0) | 123 (45.1) | 126 (46.2) | 0.886 |
Hypertension | 138 (50.5) | 162 (60.0) | 177 (64.8) | 201 (73.6) | < 0.001 |
Diabetes mellitus | 21 (7.7) | 45 (16.5) | 81 (29.7) | 123 (45.1) | < 0.001 |
Anemia | 33 (12.1) | 26 (9.5) | 30 (11.0) | 35 (12.8) | 0.322 |
Previous AMI | 6 (2.2) | 6 (2.2) | 7 (2.6) | 8 (2.9) | 0.489 |
Atrial fibrillation | 16 (5.8) | 13 (4.8) | 17 (6.2) | 15 (5.5) | 0.652 |
Biochemical indicators | |||||
NT-proBNP, pg/mL (IQR) | 525.5 (31.0–2193.2) | 534.4 (53.5–2293.7) | 527.6 (34.9–2401.4) | 546 (71.2–2603.2) | 0.179 |
Cardiac troponin I, ng/ml (IQR) | 12.2 (3.01–22.7) | 11.6 (2.7–23.1) | 13.1 (2.3–23.9) | 12.7 (2.6–24.2) | 0.762 |
hs-CRP, mg/L (IQR) | 7.9 (5.5–10.4) | 7.3 (4.4–11.1) | 6.9 (3.9–9.7) | 7.3 (3.4–10.7) | 0.652 |
White blood cells, 109/L | 9.9 ± 3.9 | 10.0 ± 3.9 | 10.0 ± 3.2 | 10.2 ± 3.2 | 0.826 |
Neutrophil ratio | 75.5 ± 10.3 | 76.2 ± 11.4 | 75.2 ± 13.6 | 75.9 ± 12.9 | 0.775 |
Platelet, 109/L | 195.0 ± 56.1 | 201.8 ± 60.5 | 228.8 ± 63.0 | 223.8 ± 53.9 | < 0.001 |
Albumin, g/L | 36.1 ± 4.8 | 37.3 ± 4.1 | 37.6 ± 4.5 | 38.2 ± 5.2 | 0.022 |
FPG, mmol/L | 6.6 ± 1.9 | 7.1 ± 1.8 | 8.1 ± 2.4 | 11.7 ± 6.0 | < 0.001 |
Measured HbA1c, % (IQR) | 6.5 (6.2–6.8) | 7.1 (6.9–7.4) | 7.6 (7.5–7.8) | 8.0 (7.9–8.2) | < 0.001 |
TC, mmol/L | 4.0 ± 0.9 | 4.3 ± 1.0 | 4.8 ± 1.2 | 5.2 ± 1.3 | < 0.001 |
Triglycerides, mmol/L | 0.9 ± 0.3 | 1.4 ± 0.3 | 1.9 ± 0.6 | 3.6 ± 2.6 | < 0.001 |
HDL-C, mmol/L | 1.0 ± 0.3 | 1.1 ± 0.2 | 1.2 ± 0.3 | 1.2 ± 0.3 | < 0.001 |
LDL-C, mmol/L | 2.4 ± 0.7 | 2.7 ± 0.8 | 3.0 ± 1.0 | 3.1 ± 0.8 | < 0.001 |
Uric acid, umol/L | 319.5 ± 102.6 | 325.5 ± 87.3 | 342.2 ± 109.3 | 347.4 ± 100.6 | 0.019 |
eGFR, mL/min | 87.0 ± 32.8 | 85.4 ± 42.0 | 86.9 ± 34.3 | 89.5 ± 39.1 | 0.423 |
Coronary angiography | |||||
GPIIb/IIIa antagonists | 91 (33.3) | 89 (32.6) | 86 (31.8) | 92 (33.7) | 0.644 |
Anticoagulation | 25 (9.2) | 27 (9.9) | 22 (8.1) | 24 (8.8) | 0.546 |
Lesion vessels | 3.2 ± 1.6 | 3.2 ± 1.5 | 3.0 ± 1.8 | 3.1 ± 1.3 | 0.743 |
Three-vessel disease | 105 (38.5) | 138 (50.5) | 150 (54.9) | 168 (61.5) | < 0.001 |
Number of stents | 1.03 ± 0.54 | 1.02 ± 0.47 | 1.02 ± 0.45 | 1.11 ± 0.50 | 0.114 |
Gensini score, (IQR) | 61.6 (49.3–75.7) | 65.4 (54.1–72.6) | 71.6 (60.9–79.3) | 78.3 (63.1–83.9) | 0.049 |
Echocardiography | |||||
LVEF | 0.55 ± 0.12 | 0.54 ± 0.10 | 0.56 ± 0.10 | 0.55 ± 0.12 | 0.335 |
Medications use at discharge | |||||
Aspirin | 255 (93.4) | 264 (96.7) | 264 (96.7) | 267 (97.8) | 0.059 |
Clopidogrel/Ticagrelor | 267 (97.8) | 270 (98.9) | 267 (97.8) | 273 (100) | 0.082 |
Statin | 261 (95.6) | 265 (97.1) | 267 (97.8) | 260 (95.2) | 0.321 |
Beta blockers | 215 (78.8) | 228 (83.5) | 210 (76.4) | 223 (81.1) | 0.247 |
ACEI/ARB | 168 (61.1) | 180 (65.5) | 171 (62.2) | 183 (66.5) | 0.205 |